Product Reports Resources Pricing Login Book a demo

Resilience

Biotech & Life Sciences · San Diego, United States · Founded 2020

Broadening access to complex medicines and protecting biopharmaceutical supply chains against disruption

Talent graph

Resilience's talent

Book a demo to see the people
Employees mapped 1,304 incl. 6 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 9 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 4 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

7 investors on Resilience's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage
Series B+ 6 investors entered at this stage

Global footprint

Where Resilience has talent and traffic

Workforce by country
6 countries with
team presence
🇺🇸 United States80.8%
🇨🇦 Canada18.3%
🇦🇪 United Arab Emirates0.2%
🇮🇳 India0.2%
🇬🇧 United Kingdom0.1%
Top 5 of 6 shown
Web traffic by country
19K monthly visits
across markets
🇺🇸 United States68.9%
🇨🇦 Canada18.9%
🇮🇳 India5.8%
🇸🇦 Saudi Arabia2.6%
🇬🇧 United Kingdom1.6%
Top 5 markets shown

Patent intelligence

$25M patent portfolio · 24 active families

Estimated portfolio value
$25M
0.66% of valuation · 5.1× smaller than top peer Zymeworks ($125M)
24 active patent families
Where Resilience innovates BioinformaticsCellGeneHemoglobinMolecular biology

Where Resilience concentrates vs peers

Each axis is a top-10 topic across Resilience and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

Resilience's 5 investments and acquisitions.

Every disclosed deal where Resilience appeared as a backer or acquirer, 2021–2021. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

5 deals across Resilience's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        01 · Deployment strategy vs peers

        Where Resilience deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        02 · Portfolio market map

        Resilience's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        5 of 5 deals

        Market sentiment

        What the market is saying about Resilience

        An AI-synthesized read of the highest-engagement posts about Resilience on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Resilience on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.